Mirova decreased its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 36.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,706 shares of the company's stock after selling 24,694 shares during the quarter. Procter & Gamble makes up approximately 1.2% of Mirova's portfolio, making the stock its 16th largest holding. Mirova's holdings in Procter & Gamble were worth $7,160,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Lakeridge Wealth Management LLC grew its stake in shares of Procter & Gamble by 0.6% in the fourth quarter. Lakeridge Wealth Management LLC now owns 10,807 shares of the company's stock worth $1,812,000 after acquiring an additional 60 shares during the last quarter. Colton Groome Financial Advisors LLC grew its position in Procter & Gamble by 3.2% in the 4th quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company's stock worth $334,000 after purchasing an additional 62 shares during the last quarter. Tevis Investment Management increased its holdings in shares of Procter & Gamble by 0.6% during the 4th quarter. Tevis Investment Management now owns 11,633 shares of the company's stock worth $1,950,000 after purchasing an additional 65 shares during the period. Dakota Community Bank & Trust NA raised its position in shares of Procter & Gamble by 3.3% during the fourth quarter. Dakota Community Bank & Trust NA now owns 2,078 shares of the company's stock valued at $348,000 after buying an additional 66 shares during the last quarter. Finally, Alhambra Investment Management LLC lifted its stake in shares of Procter & Gamble by 1.2% in the fourth quarter. Alhambra Investment Management LLC now owns 5,785 shares of the company's stock valued at $970,000 after buying an additional 66 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Trading Down 4.0 %
NYSE:PG traded down $6.69 during trading hours on Thursday, hitting $159.04. 10,490,228 shares of the stock were exchanged, compared to its average volume of 8,162,830. The company has a market capitalization of $372.92 billion, a P/E ratio of 25.32, a price-to-earnings-growth ratio of 3.76 and a beta of 0.43. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The company's 50 day moving average is $168.31 and its two-hundred day moving average is $168.43. The Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.03). The firm had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. During the same period last year, the company earned $1.52 EPS. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Monday, April 21st will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.66%. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date is Monday, April 21st. Procter & Gamble's payout ratio is 67.20%.
Analyst Ratings Changes
A number of brokerages have commented on PG. Stifel Nicolaus raised their price objective on Procter & Gamble from $161.00 to $165.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Truist Financial lifted their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a "buy" rating in a research note on Thursday, April 3rd. Wells Fargo & Company raised their price objective on shares of Procter & Gamble from $176.00 to $180.00 and gave the stock an "overweight" rating in a report on Thursday, January 23rd. UBS Group reissued a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Finally, DA Davidson restated a "buy" rating and set a $209.00 price target on shares of Procter & Gamble in a research note on Thursday, January 23rd. Seven analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $181.50.
Get Our Latest Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 35,000 shares of the company's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $173.68, for a total value of $6,078,800.00. Following the completion of the sale, the chief executive officer now owns 22,051 shares in the company, valued at approximately $3,829,817.68. This represents a 61.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.